TrialAnnals of oncology : official journal of the European Society for Medical Oncology2010

Nuclear factor-kappa B pathway and response in a phase II trial of bortezomib and docetaxel in patients with recurrent and/or metastatic head and neck squamous cell carcinoma.

C H Chung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.